Skip to main content
. 2020 Aug 14;69(32):1058–1063. doi: 10.15585/mmwr.mm6932a2

TABLE. Maternal characteristics by marijuana use and cessation during pregnancy among women who used marijuana before pregnancy – eight states,* Pregnancy Risk Assessment Monitoring System (PRAMS), 2017.

Maternal characteristic Prepregnancy use
weighted % (95% CI) (n = 765) Marijuana use status during pregnancy
weighted % (95% CI)
aPR§ (95% CI)
Continuous use
(n = 410) Cease use
(n = 355)
Total

41.2 (35.1–47.6)
58.8 (52.4–64.9)

Age group, yrs
<20
7.9 (4.8–12.6)
45.4 (23.5–69.2)
54.6 (30.8–76.5)
1.0 (0.5–2.1)
20–24
26.3 (21.1–32.2)
52.6 (40.7–64.3)
47.4 (35.7–59.3)
1.2 (0.7–2.1)
25–34
54.3 (47.8–60.6)
37.5 (29.7–45.9)
62.5 (54.1–70.3)
1.2 (0.7–1.9)
≥35
11.6 (7.9–16.6)
30.2 (14.3–53.0)
69.8 (47.0–85.7)
Referent
Race/Ethnicity
White, non-Hispanic
64.5 (57.8–70.7)
41.9 (34.5–49.5)
58.2 (50.5–65.5)
1.8 (1.1–3.2)
Black, non-Hispanic
15.4 (11.0–21.2)
28.3 (16.3–44.4)
71.7 (55.6–83.8)
Referent
Hispanic
13.6 (9.4–19.4)
41.4 (24.1–61.1)
58.6 (38.9–75.9)
1.7 (1.0–3.0)
Other**
6.5 (4.1–10.2)
70.0 (47.6–85.7)
30.0 (14.3–52.4)
2.5 (1.4–4.5)
Marital status
Married
33.5 (27.8–39.6)
22.2 (15.4–31.1)††
77.8 (68.9–84.7)††
Referent
Not married
66.6 (60.4–72.2)
50.7 (42.5–58.9)††
49.3 (41.1–57.5)††
1.7 (1.1–2.6)
Education, yrs




<12
13.6 (9.6–19.1)
75.1 (59.3–86.2)††
24.9 (13.8–40.7)††
1.9 (1.3–2.8)
12
30.1 (24.7–36.1)
58.0 (46.9–68.4)††
42.0 (31.6–53.1)††
1.6 (1.1–2.2)
>12
56.3 (49.8–62.5)
23.8 (17.8–31.2)††
76.2 (68.9–82.3)††
Referent
Insurance status during prenatal care§§
Medicaid
51.2 (44.7–57.6)
53.8 (44.7–62.6)††
46.2 (37.4–55.3)††
1.0 (0.8–1.4)
Private¶¶
44.1 (37.8–50.6)
24.1 (17.1–32.9)††
75.9 (67.1–82.9)††
Referent
Other***
4.4 (2.0–9.2)
60.1 (25.8–86.7)††
39.9 (13.3–74.2)††
1.0 (0.4–2.7)
None
0.3 (0.2–0.7)
†††
†††
1.2 (0.7–2.2)
Parity
First birth
47.6 (41.2–54.1)
34.9 (27.1–43.7)
65.1 (56.3–72.9)
Referent
Second or later birth
52.4 (45.9–58.8)
47.0 (38.2–56.0)
53.0 (44.0–61.8)
1.1 (0.8–1.4)
Entry into prenatal care




First trimester
80.2 (74.4–85.0)
38.9 (31.9–46.5)
61.1 (53.5–68.1)
Referent
Second trimester
15.7 (11.4–21.2)
48.5 (32.5–64.9)
51.5 (35.1–67.6)
1.0 (0.7–1.5)
Third trimester/None
4.2 (2.3–7.5)
68.4 (36.6–89.1)
31.6 (10.9–63.4)
1.4 (0.9–2.3)
Cigarette use during pregnancy§§§
Yes
29.6 (24.1–35.8)
73.7 (62.5–82.5)††
26.3 (17.5–37.5)††
1.6 (1.2–2.3)
No
70.4 (64.2–75.9)
27.6 (21.6–34.4)††
72.4 (65.6–78.4)††
Referent
Electronic nicotine cigarette use during pregnancy
Yes
3.4 (1.8–6.2)
78.0 (45.8–93.7)
22.1 (6.3–54.2)
1.2 (0.6–2.1)
No 96.6 (93.8–98.2) 40.1 (33.9–46.6) 59.9 (53.4–66.1) Referent

Abbreviations: aPR = adjusted prevalence ratio; CI = confidence interval.

* Alaska, Illinois, Maine, New Mexico, New York, North Dakota, Pennsylvania, and West Virginia.

Unweighted.

§ Among prepregnancy marijuana users, the association between continued use during pregnancy and maternal characteristics controlling for all other characteristics (unweighted n = 675).

Adjusted prevalence ratio statistically significant (p<0.05).

** Other race/ethnicity includes persons who were not Hispanic and whose race was Alaska native, American Indian, Asian, Chinese, Filipino, Hawaiian, Japanese, other nonwhite, or mixed race.

†† Chi–square tests indicated that characteristic was significantly different (p<0.05) across marijuana use during pregnancy.

§§ Observations with no prenatal care or missing information on insurance during prenatal care were imputed with value for insurance during delivery.

¶¶ Includes Civilian Health and Medical Program of the Uniformed Services (CHAMPUS) and TRICARE.

*** Includes Children’s Health Insurance Program and other state government programs.

††† Suppressed because cell sizes <5.

§§§ Ascertained from PRAMS and birth certificate.